🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉 🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉
Johnson & Johnson continues $2 B investment commitment with new facility in US

Johnson & Johnson has announced that it will increase its presence in North Carolina with a 160,000+ square foo...

August 25, 2025 | Monday | News
BioDlink's Bevacizumab receives approval for market launch in Indonesia

China's BioDlink has announced that its Bevacizumab Injection has obtained marketing authorisation from&n...

August 22, 2025 | Friday | News
XtalPi partners with Dong-A ST focusing on immunology and inflammation therapies

China-based startup XtalPi has signed a Memorandum of Understanding (MoU) with Korea's leading pharmaceutical company Do...

August 20, 2025 | Wednesday | News
Nicox and Kowa sign €191.5 M deal for glaucoma treatment

Paris-based Nicox SA, an international ophthalmology company, has announced the signing of a major new agreement concern...

August 19, 2025 | Tuesday | News
Skyhawk Therapeutics inks $2 B deal with Merck to discover novel RNA-targeting small molecules for neurological disorders

US-based startup Skyhawk Therapeutics, Inc., a leader in the discovery and development of small molecules that modulate ...

August 18, 2025 | Monday | News
Philips plans investment of $150 M in US to expand production of AI-based innovations

Philips, a global leader in health technology, has announced a plan for new investments of more than $150 million i...

August 15, 2025 | Friday | News
Solo-Dex and Polymedicure to bring opioid-free acute pain management to major Asian markets

Solo-Dex, Inc., a US-based medical device innovator, and Polymedicure Ltd., India's leading manufacturer of high-quality...

August 14, 2025 | Thursday | News
Kexing Biopharm teams up with IQVIA to accelerate global expansion

China-based Kexing Biopharm has entered into a comprehensive strategic partnership with IQVIA, a global leader...

August 13, 2025 | Wednesday | News
Japan's Solasia Pharma licenses DARVIAS and Episil to Firebird for 19 countries

Japan-based Solasia Pharma has entered into a licensing agreement with Firebird Biologics (headquartered in Singapore) g...

August 12, 2025 | Tuesday | News
China's Fosun Pharma licenses DPP-1 inhibitor to Expedition Therapeutics for $645 M

China-based Fosun Pharma has signed a license agreement with Expedition Therapeutics Inc. to grant the rights to de...

August 12, 2025 | Tuesday | News
Thermo Fisher receives US FDA approval for NGS-based Oncomine Dx Target Test as companion diagnostic

Thermo Fisher Scientific, the world leader in serving science, has received approval from the US Food and Drug Administr...

August 12, 2025 | Tuesday | News
Shimadzu to launch particle analysis system in Japan and overseas for analysis of microplastics

Shimadzu will launch a particle analysis system in Japan and overseas, specialising in the analysis of micropl...

August 11, 2025 | Monday | News
Korean medical aesthetic firm Hugel launches botulinum toxin Letybo in Malaysia

South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin p...

August 11, 2025 | Monday | News
Sanofi strengthens efforts to prevent Chronic Respiratory Diseases in UAE

The Ministry of Health and Prevention (MoHAP) in the UAE has signed a Memorandum of Understanding (MoU) with Sanofi...

August 9, 2025 | Saturday | News
Astria licenses rare disease drug Navenibart to Japan’s Kaken Pharma in $32 M deal

Astria Therapeutics, Inc. a US-based biopharmaceutical company, has exclusively licensed development and commercial...

August 8, 2025 | Friday | News
Cartherics unveils cleanroom facility for cell therapy manufacturing in Australia

 Cartherics, an Australia-based biotechnology company developing off-the-shelf immune stem cell therapies focusing on ...

August 9, 2025 | Saturday | News
Biocair announces APAC expansion with new office in Shanghai

Biocair, an established global leader in life science logistics, has announced further expansion of its operations in th...

August 8, 2025 | Friday | News
Excellos, Lonza, and Akadeum Life Sciences unite to advance cell therapy manufacturing

Excellos, Lonza, and Akadeum Life Sciences have announced a new project aimed at redefining standards for cell therapy m...

August 7, 2025 | Thursday | News